The Impact of NOD2 Genetic Variants on the Gut Mycobiota in Crohn's Disease Patients in Remission and in Individuals Without Gastrointestinal Inflammation.

导出 OA

翻译打印收藏纠错

作者： Andrew,Nelson ^[1] ; Christopher J,Stewart ^[2] ; Nicholas A,Kennedy ^[3] ; John K,Lodge ^[4] ; Mark,Tremelling ^[1] ; UK IBD Genetics Consortium ^[5] ; Chris S,Probert ^[6] ; Miles,Parkes ^[7] ; John C,Mansfield ^[8] ; Darren L,Smith ^[2] ; Georgina L,Hold ^[9] ; Charlie W,Lees ^[1] ; Simon H,Bridge ^[10] ; Christopher A,Lamb ^[11]

作者单位： Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK. ^[1] Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK. ^[2] IBD Pharmacogenetics Group, University of Exeter, Exeter, UK. ^[3] Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK. ^[4] Department of Gastroenterology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK. ^[5] Institute of Translational Medicine, University of Liverpool, Liverpool, UK. ^[6] Department of Gastroenterology, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK. ^[7] Department of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. ^[8] Department of Gastroenterology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK. ^[9] Gastrointestinal Research Group, University of Aberdeen, Aberdeen, UK. ^[10] Microbiome Research Centre, St George and Sutherland Clinical School, University of New South Wales, Sydney, NSW, Australia. ^[11] Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK. ^[12] Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK. ^[13]

关键词 NOD2 genotype Crohn’s disease gut mycobiota